Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 932-940

  Chakravorty, Soumitesh ^a   Aladegbami, Bola ^a,f   Thoms, Kimberley ^a,g   Lee, Jong Seok ^b   Lee, Eun Gae ^c,d   Rajan, Vignesh ^d   Cho, Eun Jin ^b   Kim, Hyunchul ^b   Kwak, Hyunkyung ^b   Kurepina, Natalia ^e   Cho, Sang Nae ^b,c   Kreiswirth, Barry ^e   Via, Laura E ^d   Barry III, Clifton E ^d   Alland, David ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b International Tuberculosis Research Center   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM MUTANT; DNA SEQUENCE; GENE MUTATION; GYRA GENE; MELTING POINT; MOLECULAR BEACON; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; DNA GYRASE; DNA PRIMERS; DNA, BACTERIAL; FLUOROQUINOLONES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; TRANSITION TEMPERATURE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79952338421     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02271-10     Document Type: Article

References (31)

1. Blaas, S. H., et al. 2008. Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases. BMC Infect. Dis. 8:60.
2. Blakemore, R., et al. 2010. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 48:2495-2501.
3. Blumberg, H. M., et al. 2003. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 167:603-662.
4. Chakravorty, S., et al. 2010. Rapid universal identification of bacterial pathogens from clinical cultures by using a novel sloppy molecular beacon melting temperature signature technique. J. Clin. Microbiol. 48:258-267.
5. Chakravorty, S., et al. 2008. Rifampin resistance, Beijing-W clade-single nucleotide polymorphism cluster group 2 phylogeny, and the Rv2629 191-C allele in Mycobacterium tuberculosis strains. J. Clin. Microbiol. 46:2555-2560.
6. Cheng, A. F., et al. 2004. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob. Agents Chemother. 48:596-601.
7. Dauendorffer, J. N., et al. 2003. Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes. J. Clin. Microbiol. 41:1311-1315.
8. Devasia, R. A., et al. 2009. Fluoroquinolone resistance in Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 180:365-370.
9. Duong, D. A., et al. 2009. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob. Agents Chemother. 53:4835-4839.
10. El-Hajj, H. H., et al. 2009. Use of sloppy molecular beacon probes for identification of mycobacterial species. J. Clin. Microbiol. 47:1190-1198.
11. Feuerriegel, S., et al. 2009. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob. Agents Chemother. 53:3353-3356.
12. Fluit, A. C., M. R. Visser, and F. J. Schmitz. 2001. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14:836-871.
13. Giannoni, F., et al. 2005. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:2928-2933.
14. Ginsburg, A. S., J. H. Grosset, and W. R. Bishai. 2003. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect. Dis. 3:432-442.
15. Ginsburg, A. S., et al. 2003. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin. Infect. Dis. 37:1448-1452.
16. Ginsburg, A. S., et al. 2005. Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model. Antimicrob. Agents Chemother. 49:3977-3979.
17. Grimaldo, E. R., et al. 2001. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Int. J. Tuberc. Lung Dis. 5:546-550.
18. Guillemin, I., V. Jarlier, and E. Cambau. 1998. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob. Agents Chemother. 42:2084-2088.
19. Helb, D., et al. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48:229-237.
20. Higuchi, R., C. Fockler, G. Dollinger, and R. Watson. 1993. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 11:1026-1030. (Pubitemid 23254023)
21. Hillemann, D., S. Rusch-Gerdes, and E. Richter. 2009. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47:1767-1772.
22. Kaplan, G., et al. 2003. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun. 71:7099-7108.
23. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
24. O'Brien, R. J. 2003. Development of fluoroquinolones as first-line drugs for tuberculosis-at long last! Am. J. Respir. Crit. Care Med. 168:1266-1268.
25. Reichman, L. B. 2008. Tuberculosis drug resistance comes full circle. Lancet 371:1052-1053. (Pubitemid 351417992)
26. Shi, R., K. Otomo, H. Yamada, T. Tatsumi, and I. Sugawara. 2006. Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. Microbes Infect. 8:128-135. (Pubitemid 43139300)
27. Takiff, H. E., et al. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
28. Umubyeyi, A. N., et al. 2007. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey. J. Antimicrob. Chemother. 59:1031-1033.
29. van Doorn, H. R., et al. 2008. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. Int. J. Tuberc. Lung Dis. 12:736-742.
30. Xu, P., et al. 2009. Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China. Antimicrob. Agents Chemother. 53:3170-3172.
31. Yew, W. W., et al. 2000. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest 117:744-751. (Pubitemid 30152215)